NASDAQ:NITE - Nightstar Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$25.54 0.00 (0.00 %)
(As of 04/24/2019 04:00 PM ET)
Previous Close$25.54
Today's Range$25.52 - $25.55
52-Week Range$9.59 - $29.55
Volume32,222 shs
Average Volume358,826 shs
Market Capitalization$717.67 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Nightstar Therapeutics (NASDAQ:NITE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for Nightstar Therapeutics in the last 12 months. Their average twelve-month price target is $28.3680, suggesting that the stock has a possible upside of 11.07%. The high price target for NITE is $40.00 and the low price target for NITE is $25.18. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $28.3680$28.3680$32.8889$34.4286
Price Target Upside: 11.07% upside12.17% upside150.68% upside129.07% upside

Nightstar Therapeutics (NASDAQ:NITE) Consensus Price Target History

Price Target History for Nightstar Therapeutics (NASDAQ:NITE)

Nightstar Therapeutics (NASDAQ:NITE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/25/2019BarclaysDowngradeOverweight ➝ Equal Weight$28.00 ➝ $26.00LowView Rating Details
3/5/2019Leerink SwannDowngradeOutperform ➝ Market Perform$25.18LowView Rating Details
3/5/2019Svb LeerinkDowngradeOutperform ➝ Market Perform$35.00 ➝ $25.50LowView Rating Details
3/5/2019MizuhoDowngradeBuy ➝ Neutral$22.00 ➝ $25.50HighView Rating Details
3/5/2019UBS GroupDowngradeBuy ➝ Neutral$21.00 ➝ $25.50HighView Rating Details
3/4/2019Chardan CapitalReiterated RatingBuy ➝ BuyLowView Rating Details
3/4/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$41.00 ➝ $25.50LowView Rating Details
3/4/2019WedbushDowngradeOutperform ➝ NeutralLowView Rating Details
3/4/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$42.00 ➝ $25.50HighView Rating Details
8/22/2018Janney Montgomery ScottInitiated CoverageBuy$34.00MediumView Rating Details
10/23/2017Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$25.00N/AView Rating Details
(Data available from 4/24/2017 forward)
This page was last updated on 4/24/2019 by Staff

Featured Article: Treasury Bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel